Key result
Metabolic syndrome was associated with an increased risk of left ventricular hypertrophy (adjusted OR 1.39) and abnormal left ventricular geometry in community-based hypertensive Han Chinese patients.
Why the study?
Is metabolic syndrome associated with increased left ventricular mass and abnormal geometry in community-based hypertensive Han Chinese patients?
Cross-Sectional (n=4,106)
Yes
Is metabolic syndrome associated with increased left ventricular mass and abnormal geometry in community-based hypertensive Han Chinese patients?
Odds Ratio: 1.39 (95% CI 1.22–1.59)
Metabolic syndrome in hypertensive patients is associated with increased left ventricular mass and abnormal geometry, particularly in females, suggesting a compounded risk for target organ damage.
May indicate compounded cardiac risk in this hypertensive population; leaves open causality and generalizability to other groups.
BACKGROUND: The association of metabolic syndrome (MS) with left ventricular (LV) hypertrophy is controversial. The objective of our study was to investigate the influence of MS on LV mass and geometry in community-based hypertensive patients among Han Chinese. MATERIALS AND METHODS: This study included 1733 metabolic syndrome patients according to the International Diabetes Federation (IDF) definition and 2373 non-MS hypertension patients. LV hypertrophy was diagnosed by the criteria of LV mass ≥49.2 g/m(2.7) for men and 46.7 g/m(2.7) for women. LV geometric patterns (normal, concentric remodeling, concentric or eccentric hypertrophy) were calculated according to LV hypertrophy and relative wall thickness. Logistic regression analysis was used to determine odds ratio (OR) and 95% confidence interval (CI) of MS for LV hypertrophy and LV geometry abnormality. RESULTS: The LV mass and LV mass index were higher in the MS group than in the non-MS group. In multiple adjusted models. LV mass index, LV mass, interventricular septum, and post wall were raised with the increased number of MS disorders. MS was associated with increased LV hypertrophy risk (unadjusted OR 1.38; 95% CI 1.21-1.57); age, sex, and blood pressure (BP; adjusted OR 1.39; 95% CI 1.22-1.59). MS was also associated with increased risk of eccentric hypertrophy in male and female patients. MS was only associated with increased risk of concentric hypertrophy in female patients; and MS was not associated with concentric remodeling. CONCLUSION: LV mass and LV mass index were associated with the increased number of MS disorders in the Chinese community-based hypertensive population. MS was not only associated with increased LV hypertrophy risk, but also associated with concentric and eccentric LV geometry abnormality, especially in females.
No takes yet. Share an insight, caveat, or question.
Hui et al. (2015) conducted a cross-sectional in Hypertension (n=4,106). Metabolic syndrome vs. Non-metabolic syndrome was evaluated on Left ventricular hypertrophy (OR 1.39, 95% CI 1.22-1.59). Metabolic syndrome was associated with an increased risk of left ventricular hypertrophy (adjusted OR 1.39) and abnormal left ventricular geometry in community-based hypertensive Han Chinese patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: